Safety Assessment of Autologous Stem Cell Combination Therapy in Patients With Decompensated Liver Cirrhosis: A Pilot Study-Reference-Cited by-同舟云学术

Safety Assessment of Autologous Stem Cell Combination Therapy in Patients With Decompensated Liver Cirrhosis: A Pilot Study

Published:2022-01 Issue:1 Volume:12 Page:80-88
ISSN:0973-6883
Container-title:Journal of Clinical and Experimental Hepatology
language:en
Short-container-title:Journal of Clinical and Experimental Hepatology

Author:

Sharma Mithun^ORCID,Pondugala Pavan K.,Jaggaihgari Shashidhar,Mitnala Sasikala,Krishna Vemula V.,Jaishetwar Ganesh,Naik Pragati,Kumar Pramod,Kulkarni Anand,Gupta Rajesh,Singh Jagdeesh R.,Darisetty Santosh,Sekharan Anuradha,Reddy Duvurr N.,Rao Guduru V.,Syeda Fatima^ORCID,Jagtap Nitin^ORCID,Rao Padaki N.

Publisher

Elsevier BV

Subject

Hepatology

Reference36 articles.

1. Burden of liver diseases in the world;Asrani;J Hepatol,2019

2. Risk factors for liver transplantation waiting list mortality;Fink;J Gastroenterol Hepatol,2007

3. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial;Lin;Hepatology,2017

4. Cell transplantation as a non-invasive strategy for treating liver fibrosis;Matsumoto;Expet Rev Gastroenterol Hepatol,2016

5. Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis;Sharma;World J Gastroenterol,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPARγ-dependent hepatic macrophage switching acts as a central hub for hUCMSC-mediated alleviation of decompensated liver cirrhosis in rats;Stem Cell Research & Therapy;2023-07-27

2. PPARγ-dependent hepatic macrophage switching acts as a central hub for hUCMSCs-mediated alleviation of decompensated liver cirrhosis in rats;2022-11-08

3. The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases;Cells;2022-04-21